Diversified Healthcare (DHC) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $7.59, -0.26% vs the prior close of $7.61.
- Volume 1.20M shares, 0.7x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
DHC ends flat (-0.3%) to $7.59. Closed at $7.59, -0.26% vs the prior close of $7.61. Day range $7.55–$7.71, opened at $7.63.
DHC daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — DHC ends flat (-0.3%) to $7.59
- Closed at $7.59, -0.26% vs the prior close of $7.61. Day range $7.55–$7.71, opened at $7.63.
- Volume was 1.20M shares, 0.7x its 50-day average of 1.85M.
- Price is -3.6% vs its 50-day average ($7.88) and -0.8% vs its 200-day average ($7.65).
- 52-week range $3.92–$9.66; today's close sits at 64% of that range, 21.4% below the 52-week high.
Oct 15, 2026 — DHC rises 1.9% to $7.61
- Closed at $7.61, +1.87% vs the prior close of $7.47. Day range $7.50–$7.63, opened at $7.57.
- Volume was 1.04M shares, 0.6x its 50-day average of 1.89M — lighter than usual.
- Price is -3.7% vs its 50-day average ($7.90) and -0.3% vs its 200-day average ($7.63).
- 52-week range $3.92–$9.66; today's close sits at 64% of that range, 21.2% below the 52-week high.
Oct 14, 2026 — DHC dips 2.0% to $7.47, a 3-month low
- Closed at $7.47, -1.97% vs the prior close of $7.62. Day range $7.44–$7.67, opened at $7.58.
- Volume was 2.10M shares, 1.1x its 50-day average of 1.94M.
- Price is -5.8% vs its 50-day average ($7.93) and -2.0% vs its 200-day average ($7.62).
- 52-week range $3.92–$9.66; today's close sits at 62% of that range, 22.7% below the 52-week high.
Oct 13, 2026 — DHC ends flat (+0.0%) to $7.62
- Closed at $7.62, +0.00% vs the prior close of $7.62. Day range $7.55–$7.72, opened at $7.72.
- Volume was 2.54M shares, 1.3x its 50-day average of 1.94M.
- Price is -4.2% vs its 50-day average ($7.96) and +0.2% vs its 200-day average ($7.61).
- 52-week range $3.92–$9.66; today's close sits at 64% of that range, 21.1% below the 52-week high.
Oct 12, 2026 — DHC rises 1.6% to $7.62
- Closed at $7.62, +1.60% vs the prior close of $7.50. Day range $7.43–$7.69, opened at $7.47.
- Volume was 1.60M shares, 0.8x its 50-day average of 1.93M.
- Price is -4.5% vs its 50-day average ($7.98) and +0.4% vs its 200-day average ($7.59).
- 52-week range $3.92–$9.66; today's close sits at 64% of that range, 21.1% below the 52-week high.
Oct 9, 2026 — DHC dips 0.7% to $7.50
- Closed at $7.50, -0.66% vs the prior close of $7.55. Day range $7.45–$7.78, opened at $7.58.
- Volume was 1.75M shares, 0.9x its 50-day average of 1.92M.
- Price is -6.3% vs its 50-day average ($8.01) and -1.0% vs its 200-day average ($7.58).
- 52-week range $3.92–$9.66; today's close sits at 62% of that range, 22.4% below the 52-week high.
Oct 8, 2026 — DHC rises 0.4% to $7.55
- Closed at $7.55, +0.40% vs the prior close of $7.52. Day range $7.39–$7.64, opened at $7.48.
- Volume was 2.94M shares, 1.6x its 50-day average of 1.89M.
- Price is -6.0% vs its 50-day average ($8.03) and -0.2% vs its 200-day average ($7.57).
- 52-week range $3.92–$9.66; today's close sits at 63% of that range, 21.8% below the 52-week high.
Oct 7, 2026 — DHC dips 0.8% to $7.52
- Closed at $7.52, -0.79% vs the prior close of $7.58. Day range $7.50–$7.62, opened at $7.55.
- Volume was 3.00M shares, 1.6x its 50-day average of 1.86M.
- Price is -6.7% vs its 50-day average ($8.06) and -0.5% vs its 200-day average ($7.55).
- 52-week range $3.92–$9.66; today's close sits at 63% of that range, 22.2% below the 52-week high.
Oct 6, 2026 — DHC rises 0.5% to $7.58
- Closed at $7.58, +0.53% vs the prior close of $7.54. Day range $7.45–$7.67, opened at $7.59.
- Volume was 1.83M shares, 1.0x its 50-day average of 1.84M.
- Price is -6.4% vs its 50-day average ($8.10) and +0.5% vs its 200-day average ($7.54).
- 52-week range $3.92–$9.66; today's close sits at 64% of that range, 21.5% below the 52-week high.
Oct 5, 2026 — DHC dips 2.5% to $7.54, 6 down days in a row
- Closed at $7.54, -2.46% vs the prior close of $7.73. Day range $7.50–$7.75, opened at $7.71.
- Volume was 1.64M shares, 0.9x its 50-day average of 1.83M.
- Price is -7.3% vs its 50-day average ($8.13) and +0.2% vs its 200-day average ($7.53).
- 52-week range $3.92–$9.66; today's close sits at 63% of that range, 21.9% below the 52-week high.
- That makes 6 straight losses.
Oct 2, 2026 — DHC ends flat (-0.1%) to $7.73, 5 down days in a row
- Closed at $7.73, -0.13% vs the prior close of $7.74. Day range $7.69–$7.95, opened at $7.86.
- Volume was 1.91M shares, 1.1x its 50-day average of 1.81M.
- Price is -5.4% vs its 50-day average ($8.17) and +2.9% vs its 200-day average ($7.52).
- 52-week range $3.92–$9.66; today's close sits at 66% of that range, 20.0% below the 52-week high.
- That makes 5 straight losses.
DHC latest news & SEC filings
Every SEC filing by or about DHC in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 21, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Portnoy Adam D. had withheld for taxes 19,315 shares at $8.13 (≈$157.03K) on Sep 17, 2026; now holds 467,924
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 21, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Brown Matthew C. had withheld for taxes 13,895 shares at $8.13 (≈$112.97K) on Sep 17, 2026; now holds 153,109
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 21, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Bilotto Christopher J. had withheld for taxes 25,118 shares at $8.13 (≈$204.21K) on Sep 17, 2026; now holds 314,067
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 12, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 3, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $365.39M (prior year $382.71M) (-4.5% vs Jun 30, 2025)
- Net income: -$37.42M (prior year -$91.64M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.16 (prior year -$0.38) (loss narrowed vs Jun 30, 2025)
Aug 3, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 28, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade DHC
- Last results release: Aug 3, 2026 (8-K Item 2.02). Previous ones: May 4, 2026, Feb 23, 2026, Jan 14, 2026. Based on that rhythm, the next report is likely around Nov 2, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 0.91% (largest 2.5%). That is a relatively calm stock.
- Liquidity: about 2.02M shares (≈$15.35M) trade per day on average.
- 52-week position: $7.59 vs a range of $3.92–$9.66 (64% of the range).
- Dividends: last ex-dividend date Jul 20, 2026 ($0.01/share); 4 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 4 open-market buys, 0 sales; latest: Christopher J. Bilotto bought 20,000 shares on Dec 15, 2025.
- Latest filings: 10-Q Aug 3, 2026; 8-K Aug 3, 2026; 8-K Jun 12, 2026.
- Share count: 242.13M shares outstanding (Jul 31, 2026), +0.3% vs a year earlier.
- Listing: Nasdaq · industry: Real Estate Investment Trusts.
DHC market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 7.63 | 7.71 | 7.55 | 7.59 | 1.20M |
| Oct 15, 2026 | 7.57 | 7.63 | 7.50 | 7.61 | 1.04M |
| Oct 14, 2026 | 7.58 | 7.67 | 7.44 | 7.47 | 2.10M |
| Oct 13, 2026 | 7.72 | 7.72 | 7.55 | 7.62 | 2.54M |
| Oct 12, 2026 | 7.47 | 7.69 | 7.43 | 7.62 | 1.60M |
| Oct 9, 2026 | 7.58 | 7.78 | 7.45 | 7.50 | 1.75M |
| Oct 8, 2026 | 7.48 | 7.64 | 7.39 | 7.55 | 2.94M |
| Oct 7, 2026 | 7.55 | 7.62 | 7.50 | 7.52 | 3.00M |
| Oct 6, 2026 | 7.59 | 7.67 | 7.45 | 7.58 | 1.83M |
| Oct 5, 2026 | 7.71 | 7.75 | 7.50 | 7.54 | 1.64M |
| Oct 2, 2026 | 7.86 | 7.95 | 7.69 | 7.73 | 1.91M |
| Oct 1, 2026 | 7.82 | 7.90 | 7.51 | 7.74 | 2.40M |
| Sep 30, 2026 | 7.93 | 7.94 | 7.77 | 7.85 | 2.48M |
| Sep 29, 2026 | 7.95 | 8.07 | 7.91 | 7.93 | 1.87M |
| Sep 28, 2026 | 8.06 | 8.12 | 7.91 | 7.96 | 1.54M |
| Sep 25, 2026 | 8.18 | 8.18 | 7.97 | 8.13 | 1.77M |
| Sep 24, 2026 | 8.12 | 8.26 | 8.00 | 8.12 | 2.29M |
| Sep 23, 2026 | 8.10 | 8.23 | 7.95 | 8.13 | 2.08M |
| Sep 22, 2026 | 8.07 | 8.28 | 8.06 | 8.17 | 2.40M |
| Sep 21, 2026 | 8.05 | 8.19 | 8.00 | 8.12 | 2.08M |
About Diversified Healthcare
Diversified Healthcare (DHC) is listed on the Nasdaq and classified by the SEC under “Real Estate Investment Trusts”. Its business address is in NEWTON, MA. State of incorporation: MD. Fiscal year ends December 31. SEC CIK 1075415.
DHC board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Christopher J. Bilotto | President and CEO | Sep 21, 2026 |
| Alan L. Felder | Director | Jun 12, 2026 |
| Phyllis M. Hollis | Director | Jun 12, 2026 |
| Lisa Harris Jones | Director | Jun 12, 2026 |
| Dawn K. Neher | Director | Jun 12, 2026 |
| Adam D. Portnoy | Director | Sep 21, 2026 |
| Jeffrey P. Somers | Director | Jun 12, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Christopher J. Bilotto | President and CEO | Sep 21, 2026 |
| Matthew C. Brown | CFO and Treasurer | Sep 21, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Dec 15, 2025 | Christopher J. Bilotto | Buy | 20,000 | $4.89 |
| Dec 15, 2025 | Christopher J. Bilotto | Buy | 20,000 | $4.89 |
| Dec 15, 2025 | Christopher J. Bilotto | Buy | 20,000 | $4.89 |
| Dec 15, 2025 | Christopher J. Bilotto | Buy | 20,000 | $4.89 |
DHC financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $1.54B | $-285.89M | -1.19 | $-19.62M |
| Dec 31, 2024 | $1.50B | $-370.25M | -1.55 | $112.22M |
| Dec 31, 2023 | $1.41B | $-293.57M | -1.23 | $10.48M |
| Dec 31, 2022 | $1.28B | $-15.77M | -0.07 | $-40.35M |
| Dec 31, 2021 | $1.38B | $174.51M | 0.73 | $-63.32M |
Latest balance sheet: total assets $4.24B, total liabilities $2.66B, cash $116.79M (as of Jun 30, 2026).
DHC earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 3, 2026 | 8-K Item 2.02 (results) | $8.81 |
| May 4, 2026 | 8-K Item 2.02 (results) | $7.76 |
| Feb 23, 2026 | 8-K Item 2.02 (results) | $6.15 |
| Jan 14, 2026 | 8-K Item 2.02 (results) | $5.35 |
| Nov 3, 2025 | 8-K Item 2.02 (results) | $4.42 |
| Aug 4, 2025 | 8-K Item 2.02 (results) | $3.41 |
| May 5, 2025 | 8-K Item 2.02 (results) | $2.18 |
| Feb 25, 2025 | 8-K Item 2.02 (results) | $2.45 |
| Nov 4, 2024 | 8-K Item 2.02 (results) | $3.52 |
| Aug 1, 2024 | 8-K Item 2.02 (results) | — |
| May 6, 2024 | 8-K Item 2.02 (results) | — |
| Feb 26, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Real Estate Investment Trusts
Welltower (WELL)American Tower (AMT)Prologis (PLD)Realty Income (O)Equinix (EQIX)Crown Castle (CCI)Ventas (VTR)AGNC Investment (AGNC)Digital Realty (DLR)Vivmark Residential (VMRK)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on DHC
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.